(Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | (Q3)Aug 31, 2022 | (Q2)May 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -198.64%-6.11K | 52.19%-30.53K | 6.94%-19K | -53.13%-10.01K | 72.94%-7.72K | 173.89%6.19K | 11.44%-63.86K | -79.44%-20.41K | -6.54K | -82.53%-28.53K |
Net income from continuing operations | 10.23%-12.38K | 15.71%-100.69K | 21.46%-58.9K | 8.11%-14.5K | 24.88%-13.49K | -28.75%-13.79K | -67.39%-119.45K | -113.07%-74.99K | ---15.78K | 20.00%-17.96K |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Change In working capital | -68.63%6.27K | 26.20%70.15K | -26.89%39.9K | -51.41%4.49K | 154.63%5.77K | 758.75%19.98K | 325.95%55.59K | 129.13%54.58K | --9.25K | -254.87%-10.57K |
-Change in receivables | -46.54%1.99K | 228.08%3.47K | 42.67%-1.93K | 138.99%363 | 319.93%1.32K | 69.70%3.71K | -154.66%-2.71K | -3,215.74%-3.37K | ---931 | -121.30%-602 |
-Change in prepaid assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --0 |
-Change in payables and accrued expense | -73.68%4.28K | 14.38%66.68K | -27.81%41.83K | -59.42%4.13K | 144.65%4.45K | 11,605.04%16.27K | 597.92%58.3K | 1,380.83%57.95K | --10.18K | -349.31%-9.97K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -198.64%-6.11K | 52.19%-30.53K | 6.94%-19K | -53.10%-10.01K | 72.94%-7.72K | 173.90%6.19K | 11.44%-63.86K | -79.45%-20.41K | ---6.54K | -82.53%-28.53K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -63.46%2.8K | 94.26%11.19K | 0 | -53.40%2.8K | -151.36%-11.19K | -3.26%7.65K | 1,180.44%5.76K | 342 | -65.01%6K |
Capital expenditure reported | --0 | ---- | ---- | --0 | --0 | -151.36%-11.19K | ---- | ---- | --342 | --0 |
Net PPE purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | 83.33%-2.35K | ---- | ---- | ---- |
Net other investing changes | ---- | -72.04%2.8K | --0 | --0 | ---- | ---- | -54.55%10K | 0.00%4K | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | -63.46%2.8K | 94.26%11.19K | --0 | -53.40%2.8K | -151.36%-11.19K | -3.26%7.65K | 1,180.44%5.76K | --342 | -65.01%6K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0.04%7.31K | -50.03%27.7K | -39.83%7.81K | 134.37%7.03K | 5.55K | -81.47%7.31K | 22.23%55.42K | 2,047.60%12.97K | 3K | 0 |
Net other financing activities | 0.04%7.31K | -50.03%27.7K | -39.83%7.81K | 134.37%7.03K | --5.55K | -81.47%7.31K | --55.42K | --12.97K | --3K | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 0.04%7.31K | -50.03%27.7K | -39.83%7.81K | 134.37%7.03K | --5.55K | -81.47%7.31K | 22.23%55.42K | 2,047.60%12.97K | --3K | --0 |
Net cash flow | ||||||||||
Beginning cash position | -55.26%34 | -91.23%76 | -98.12%33 | -39.18%3.01K | -91.31%2.39K | -91.23%76 | -95.61%867 | -85.90%1.76K | -60.25%4.95K | 151.23%27.48K |
Current changes in cash | -47.94%1.2K | 94.69%-42 | 100.06%1 | 6.79%-2.98K | 102.77%625 | -91.32%2.31K | 95.81%-791 | 85.51%-1.68K | ---3.2K | -1,583.21%-22.53K |
End cash Position | -48.18%1.24K | -55.26%34 | -55.26%34 | -98.12%33 | -39.18%3.01K | -91.31%2.39K | -91.23%76 | -91.23%76 | -85.90%1.76K | -60.25%4.95K |
Free cash from | -22.22%-6.11K | 53.88%-30.53K | 58.16%-7.8K | -61.56%-10.01K | 72.94%-7.72K | 61.05%-5K | 23.19%-66.21K | -24.96%-18.65K | ---6.2K | -73.11%-28.53K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.